Pfizer's Covid Cliff Is Here — What To Expect For 2023 – Investor's Business Daily
Business News
- Pfizer’s Covid Cliff Is Here — What To Expect For 2023 Investor’s Business Daily
- The Covid sales boom is over for Pfizer CNN
- Pfizer beats on Q4 earnings, issues weak guidance for COVID-19 vaccine Yahoo Finance
- The Covid pandemic drives Pfizer’s 2022 revenue to a record $100 billion CNBC
- Pfizer beats EPS estimates; stock falls on lower yearly guidance CNBC Television
- View Full Coverage on Google News
Source: Business News